This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Expands Medicare Offerings in New Counties
by Zacks Equity Research
UnitedHealth (UNH) is offering Medicare Advantage plans in new counties to reach a greater population of retirees.
Can Humana (HUM) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Humana Penetrates Further in New Jersey Via PPO, HMO Plan
by Zacks Equity Research
Humana (HUM) expands its footprint in New Jersey to facilitate the locals with better healthcare solutions.
Cigna Offers 2020 Medicare Plans with Supplemental Benefits
by Sapna Bagaria
Cigna (CI) is expanding its Medicare Advantage plans across states and counties along with supplemental benefits
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
3 Health Insurance Stocks Poised to Beat on Earnings in Q3
by Sapna Bagaria
Growth in government and pharmacy benefit management businesses as well as share buybacks should enhance the third-quarter earnings of health insurers.
UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
UnitedHealth to Offer Medicare Advantage Plan in Bay Area
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Cigna Expands Health Care Exchange Offerings to New Markets
by Zacks Equity Research
Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.
Humana and Seniorlink to Serve Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) collaborates with Seniorlink to unveil Virtual Care Team pilot for offering its Medicare Advantage members an improved healthcare management.
Strategic Acquisitions Aid Revenue Growth at Ensign Group
by Zacks Equity Research
Ensign Group's (ENSG) series of strategic buyouts aids its top line and the trend is expected to continue.
Here's How Cigna (CI) is Poised Amid Political Uncertainty
by Zacks Equity Research
Growth in health services, government business and international markets drive Cigna's (CI) stock.
Why Should You Retain Centene (CNC) Stock in Your Portfolio?
by Zacks Equity Research
Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.
Is Humana (HUM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Retain WellCare Health in Your Portfolio?
by Zacks Equity Research
Riding on increasing membership and inorganic growth strategies, WellCare Health (WCG) holds potential to reap benefits for investors. Besides, the company inks a merger deal with Centene in 2020.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Banking on divestitures and buyouts along with restructuring plans, Community Health (CYH) holds potential to reap benefits for investors.
Humana (HUM) Ties Up to Boost Medicare Advantage Network
by Zacks Equity Research
Humana (HUM) collaborates with Iora Health to strengthen its Medicare Advantage network across Texas, Georgia and Arizona.
Humana Ties Up to Enhance Facilities for Members in Michigan
by Zacks Equity Research
Humana (HUM) teams up with McLaren Physician Partners to provide in-network access to its members in Michigan.
Bright Near-Term Outlook for Medical Info Systems Industry
by Sreyoshi Mukherjee
Growth prospects look bright for the Zacks Medical Info Systems industry, thanks to rising need for curtailing medical expenses and AI.
Should Value Investors Consider Humana (HUM) Stock Now?
by Zacks Equity Research
Let's see if Humana (HUM) stock is a good choice for value-oriented investors right now from multiple angles.
Why is It Worth Holding Humana (HUM) in Your Portfolio?
by Zacks Equity Research
Banking high on its strong Medicare business and strategic buyouts, Humana (HUM) shows potential to reap benefits for investors, partly offset by high costs.
Centene Expands Existence in Health Insurance Marketplace
by Zacks Equity Research
Centene (CNC) to increase offerings in the 2020 Health Insurance Marketplace across 10 U.S. state markets.
Humana's (HUM) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Humana's (HUM) second-quarter earnings gain from Medicare Advantage membership growth.
Private Sector Payroll Increases In July
by Zacks Equity Research
Private Sector Payroll Increases In July
ADP Payrolls In-Line at 156K, Slowing from 2018
by Mark Vickery
156K new non-government jobs were brought to the market. This is higher than the upwardly revised 112K from June, but still lower than the 2019 average.